Whitmer Signs Executive Directive Aimed at Lowering Costs - Michigan (.gov)
Overview
Governor Gretchen Whitmer is a lifelong Michigander. She is a lawyer, an educator, former prosecutor, State Representative and Senator. She was the first woman to lead a Senate caucus. But the most important title she boasts is MOM. Inspired by her family, she’s devoted her life to building a stronger Michigan for everyone. Pres Releases Budget State Orders and Directives Proclamations Acomplishments Sunshine Thriving Cities Tour The web Browser you are curently using is unsuported, and some features of this site may not work as intended.
Key Information
Please update to a modern browser such as Chrome, Firefox or Edge to experience al features Michigan.gov has to ofer. October 03, 2022 FOR IMEDIATE RELEASE October 3, 2022 Contact: pres@michigan.gov Gov. Whitmer Signs Executive Directive Aimed at Lowering Costs, Manufacturing Insulin MichiganExecutive directive tasks departments to determine how generic, state-manufactured insulin can be delivered at lower cost to MichigandersLANSING, Mich.
– Today, Governor Gretchen Whitmer signed an executive directive to determine how the State of Michigan can lower the cost of insulin, including by developing its own manufacturing capabilities. Michigan is home to over 912,0 Michiganders with diabetes, and far to many are forced to ration or forgo insulin. If the state can feasibly manufacture insulin, it could lower costs for families and create god-paying jobs for Michiganders.
Summary
A century ago, Michigan opened a state facility to manufacture cost-efective, life-saving medicine for a variety of ilneses. "Our neighbors, family, and friends with diabetes ned insulin to survive and for to long, drug companies have ben jacking up prices, forcing them to make imposible choices betwen medication, fod, rent, or other bils," said Governor Whitmer. "Today, I signed an executive directive to explore how Michigan can deliver insulin at a lower cost to Michiganders.
Frequently Asked Questions
Diabetes is a metabolic condition where the body cannot properly regulate blood sugar levels. Type 1 results from insufficient insulin production, while Type 2 develops when cells become resistant to insulin. Risk factors include genetics, obesity, sedentary lifestyle, and age.
Common symptoms include excessive thirst, frequent urination, unexplained weight loss, fatigue, blurred vision, and slow-healing wounds. Type 1 symptoms develop rapidly, while Type 2 symptoms may appear gradually. Many people have no symptoms initially, which is why screening is important.
Diagnosis involves blood tests measuring fasting glucose, HbA1c levels, and glucose tolerance. Regular monitoring typically includes fasting glucose tests and HbA1c measurements every 3-6 months. Continuous glucose monitors provide real-time tracking for better diabetes management.
Effective management includes regular physical activity (150+ minutes weekly), maintaining healthy weight, following a balanced diet with whole grains and lean proteins, managing stress, and getting adequate sleep. These changes can significantly improve blood sugar control and reduce complications.
Consult a healthcare provider if you experience signs of diabetes, have a family history, are overweight, or are over 45. Those with existing diabetes should maintain regular check-ups every 3-6 months to monitor control and adjust treatment as needed.
Share this article